相关实验视频

Updated: Jul 1, 2025

In Vitro Modeling of Down Syndrome Neurogenesis Using Human-Induced Pluripotent Stem Cells

In Vitro Modeling of Down Syndrome Neurogenesis Using Human-Induced Pluripotent Stem Cells

Published on: March 7, 2025

三胞胎症21驱动的代谢物改变与唐氏综合征中的细胞损伤有关

Juli Liu¹, Shaoxian Chen^2,3,4, Guiping Huang²

¹Medical Research Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, 510080, Guangdong, China. liujuli@gdph.org.cn.

Cellular and molecular life sciences : CMLS

|March 3, 2024

概括

唐氏综合征的额外染色体21扰乱了细胞代谢,并导致DNA损伤. 酸是一种关键的代谢物,可以防止这种损伤,并有助于心脏发育.

科学领域:

遗传学是一个遗传学.
干细胞生物学干细胞生物学
代谢学代谢学代谢学

背景情况:

唐氏综合征 (DS) 是由三形21 (exCh21) 引起的,导致先天性疾病,但直接的分子影响仍然不清楚.
马赛克唐氏综合征患者衍生的诱导多能干细胞 (hiPSCs) 提供了一个模型,以研究 exCh21 在同源系中的效应.
了解exCh21的细胞后果对于开发有针对性的唐氏综合征疗法至关重要.

研究的目的:

研究唐氏综合征患者21号染色体额外副本 (exCh21) 的直接细胞和分子影响.
确定受 exCh21 影响的关键代谢物及其在DS相关病理中的作用.
探索卡尔西特作为DS相关发育问题的治疗剂的潜力.

主要方法:

从唐氏综合征患者的马赛克生成同源的hiPSC线,有或没有 exCh21.
转录基因和表观基因 (染色体可访问性) 分析以评估细胞变化.
代谢分析,以确定失调的代谢物和功能分析,以测试它们的影响.

主要成果:

exCh21破坏细胞转录组,诱导DNA损伤,并改变染色质的可访问性.
5-oxo-ETE和酸的生物合成受到 exCh21.0 的显著影响.
5-oxo-ETE会加剧DNA损伤,而卡尔西醇会防止这种损伤,并减轻exCh21诱导的心脏发生缺陷.

结论:

exCh21对细胞代谢,DNA完整性和唐氏综合征发育过程产生深远的影响.
酸通过抵消exCh21诱导的DNA损伤和支持心脏生成,显示出治疗潜力.
这项研究提供了对exCh21代谢效应的见解,并建议酸作为唐氏综合征的有希望的治疗点.

关键词:

5oxo-ETE的使用情况酸醇是一种酸.心脏发育的心脏的发展.遗传性心脏病是一种先天性心脏病.造成的DNA损伤是DNA损伤.

更多相关视频

One-step Metabolomics: Carbohydrates, Organic and Amino Acids Quantified in a Single Procedure

One-step Metabolomics: Carbohydrates, Organic and Amino Acids Quantified in a Single Procedure

Published on: June 25, 2010

Generation of Induced Pluripotent Stem Cells from Turner Syndrome 45XO Fetal Cells for Downstream Modelling of Neurological Deficits Associated with the Syndrome

Generation of Induced Pluripotent Stem Cells from Turner Syndrome 45XO Fetal Cells for Downstream Modelling of Neurological Deficits Associated with the Syndrome

Published on: December 4, 2021

相关概念视频

Meiosis I

Meiosis I

Meiosis is a carefully orchestrated set of cell divisions, the goal of which—in humans—is to produce haploid sperm or eggs, each containing half the number of chromosomes present in somatic cells elsewhere in the body. Meiosis I is the first such division, and involves several key steps, among them: condensation of replicated chromosomes in diploid cells; the pairing of homologous chromosomes and their exchange of information; and finally, the separation of homologous chromosomes by...

Karyotyping

Karyotyping

Meiosis vs. Mitosis

Meiosis vs. Mitosis

Cell division is necessary for growth and reproduction in organisms. Mitosis aids cell growth and development by dividing somatic cells. In contrast, meiosis causes the division of germ cells and plays an essential role in sexual reproduction. Due to their unique functional requirements, mitosis and meiosis differ from each other in multiple aspects.
Before the start of mitosis and meiosis I, the cell synthesizes DNA, resulting in two homologous copies of each chromosome. DNA synthesis is...

Nondisjunction

Nondisjunction

During meiosis, chromosomes occasionally separate improperly. This occurs due to failure of homologous chromosome separation during meiosis I or failed sister chromatid separation during meiosis II. In some species, notably plants, nondisjunction can result in an organism with an entire additional set of chromosomes, which is called polyploidy. In humans, nondisjunction can occur during male or female gametogenesis and the resulting gametes possess one too many or one too few chromosomes.

Electron Transport Chain: Complex I and II

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...

Teratogenicity

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...